Evidence of Commercial Success and the Prior Art
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
Written by: Nima Zargari, Ph.D. & Nathan D. Reeves
Before Taranto, Chen, and Stoll. Appeal from the Patent Trial and Appeal Board.
Summary: Evidence of commercial success that relates entirely to an individual claim element that was disclosed in the prior art cannot support a finding of non-obviousness.
Yita LLC challenged the claims of two U.S. patents assigned to MacNeil IP LCC before the Patent Trial and Appeal Board in two inter partes reviews (IPRs). In the first IPR, the Board determined that a relevant artisan would have been motivated to combine the teachings of the prior art references and had a reasonable expectation of success in doing so. However, the Board found MacNeil’s evidence of secondary considerations, which was linked to a particular claim limitation, compelling and indicative of non-obviousness, thus holding the claims not unpatentable for obviousness. Yita appealed.
On appeal, the Federal Circuit reversed the Board’s decision regarding the first IPR. The Federal Circuit held that the Board offered legally incorrect reasoning for rejecting Yita’s obviousness challenge based on MacNeil’s secondary-consideration evidence. The Federal Circuit recognized that secondary-consideration evidence “may be linked to an individual element” of the claimed invention or “to the inventive combination of known elements” in the prior art. However, MacNeil’s evidence of commercial success related entirely to an individual element, which was found to be disclosed in the prior art. Consequently, the Federal Circuit held that the evidence of success was not pertinent and did not undermine the obviousness of the claimed invention.
Regarding the second IPR, the Federal Circuit affirmed the Board’s decision not to consider an argument raised for the first time by Yita in a footnote in its Petitioner’s Reply.
Editor: Paul Stewart
More insights
Fresh From the Bench: Latest Precedential Patent Case
Ridge Corp. et al. v. Kirk NationaLease Co. et al. , Appeal No. 2025-1254 (Fed. Cir. July 13, 2026) In its only precedential patent opinion last week, the Federal Circuit considered an appeal of a preliminary injunction issued by the U.S. District Court…
Fresh From the Bench: Latest Precedential Patent Cases
CASE OF THE WEEK Wyeth LLC v. AstraZeneca Pharmaceuticals LP , Appeal No. 2024-2325 (Fed. Cir. July 9, 2026) In our Case of the Week, the Federal Circuit affirmed a district court ruling reversing a $107.5 million jury verdict against AstraZeneca in a case…
Enanta Pharmaceuticals, Inc. v. Pfizer Inc., Appeal No. 2025-1427 (Fed. Cir. Jun. 23, 2026)
CASE OF THE WEEK Enanta Pharmaceuticals, Inc. v. Pfizer Inc., Appeal No. 2025-1427 (Fed. Cir. Jun. 23, 2026) In our Case of the Week, the Federal Circuit affirmed summary judgment invalidating all claims of Enanta’s Patent No. 11,358,953 as…